Westwood Holdings Group’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
RIM
GCM
CRM
Westwood Holdings Group's LMAT Position: Q1 2023 in Review
Westwood Holdings Group sold out of LeMaitre Vascular (LMAT) in Q1 2023, closing a stake of 10,133 shares — an estimated $466K sold.
Westwood Holdings Group first reported a position in LMAT in Q1 2022 and held it in 4 quarters. The position peaked at $482K in Q3 2022. 184 funds tracked by Wall St. Rank hold LMAT as of Q1 2023.
- Westwood Holdings Group reported no remaining LeMaitre Vascular position as of Q1 2023 after selling out during the quarter.
- Westwood Holdings Group sold 10,133 LeMaitre Vascular shares in Q1 2023, an estimated $466K.
- Westwood Holdings Group first reported a position in LeMaitre Vascular in Q1 2022 and held it in 4 quarters.
- Westwood Holdings Group's LeMaitre Vascular position peaked at $482K in Q3 2022.
- 184 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2023.
Based on Westwood Holdings Group's 13F filing for Q1 2023, filed 12 May 2023.